Kenyon Chris
HIV/STI Unit, Institute of Tropical Medicine, 2000 Antwerp, Belgium.
Division of Infectious Diseases and HIV Medicine, University of Cape Town, Anzio Road, Cape Town 7700, South Africa.
Antibiotics (Basel). 2021 Oct 1;10(10):1193. doi: 10.3390/antibiotics10101193.
(1) Background: It is unclear what underpins the large global variations in the prevalence of fluoroquinolone resistance in Gram-negative bacteria. We tested the hypothesis that different intensities in the use of quinolones for food-animals play a role. (2) Methods: We used Spearman's correlation to assess if the country-level prevalence of fluoroquinolone resistance in human infections with , , and was correlated with the use of quinolones for food producing animals. Linear regression was used to assess the relative contributions of country-level quinolone consumption for food-animals and humans on fluoroquinolone resistance in these 4 species. (3) Results: The prevalence of fluoroquinolone resistance in each species was positively associated with quinolone use for food-producing animals ( [ρ = 0.55; < 0.001], [ρ = 0.58; < 0.001]; [ρ = 0.54; = 0.004]; [ρ = 0.48; = 0.008]). Linear regression revealed that both quinolone consumption in humans and food animals were independently associated with fluoroquinolone resistance in and . (4) Conclusions: Besides the prudent use of quinolones in humans, reducing quinolone use in food-producing animals may help retard the spread of fluoroquinolone resistance
(1) 背景:目前尚不清楚革兰氏阴性菌中氟喹诺酮耐药性全球流行率存在巨大差异的原因。我们检验了喹诺酮类药物在食用动物中的不同使用强度起作用这一假设。(2) 方法:我们使用Spearman相关性来评估人类感染大肠埃希菌、肺炎克雷伯菌、奇异变形杆菌和铜绿假单胞菌时,国家层面氟喹诺酮耐药性流行率与食用动物中喹诺酮类药物使用情况是否相关。使用线性回归来评估国家层面食用动物和人类的喹诺酮消费量对这4种细菌氟喹诺酮耐药性的相对贡献。(3) 结果:每种细菌的氟喹诺酮耐药性流行率与食用动物中喹诺酮类药物的使用呈正相关(大肠埃希菌[ρ = 0.55;P < 0.001],肺炎克雷伯菌[ρ = 0.58;P < 0.001];奇异变形杆菌[ρ = 0.54;P = 0.004];铜绿假单胞菌[ρ = 0.48;P = 0.008])。线性回归显示,人类和食用动物中的喹诺酮消费量均与大肠埃希菌和肺炎克雷伯菌的氟喹诺酮耐药性独立相关。(4) 结论:除了在人类中谨慎使用喹诺酮类药物外,减少食用动物中喹诺酮类药物的使用可能有助于延缓氟喹诺酮耐药性的传播。